(Q30398624)

English

Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

10

object named as

Albert D M E Osterhaus

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

3

object named as

Thijs Kuiken

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Geert van Amerongen

8

object named as

Geert van Amerongen

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Koert J Stittelaar

2

object named as

Koert J Stittelaar

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Benoît Baras

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Valérie Jacob

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Roger Bernhard

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sandra Giannini

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Leon de Waal

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

James H Simon

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Emmanuel Hanon

11

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sally P Mossman

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

13 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

2092-2099

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Scientific barriers to developing vaccines against avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Strategies for mitigating an influenza pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

T cell responses are better correlates of vaccine protection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

Aleutian disease in ferrets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.128

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.12.128

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30398624&oldid=1549809593"